Yahoo! Inc. (NASDAQ:YHOO) was downgraded by equities research analysts at Vetr from a “buy” rating to a “hold” rating in a report released on Thursday. They presently have a $37.11 target price on the digital content provider’s stock. Vetr‘s price objective would suggest a potential upside of 0.95% from the company’s previous close.

In other Yahoo! news, CRO Lisa Utzschneider sold 820 shares of the company’s stock in a transaction on Friday, May 20th. The shares were sold at an average price of $36.04, for a total transaction of $29,552.80. Following the transaction, the executive now owns 630,643 shares in the company, valued at $22,728,373.72. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Kenneth A. Goldman sold 200,000 shares of the company’s stock in a transaction on Tuesday, May 3rd. The stock was sold at an average price of $36.10, for a total transaction of $7,220,000.00. Following the transaction, the chief financial officer now owns 853,811 shares in the company, valued at approximately $30,822,577.10. The disclosure for this sale can be found here.

A number of hedge funds and institutional investors have added to or reduced their stakes in YHOO. NN Investment Partners Holdings N.V. acquired a new position in Yahoo! during the first quarter valued at $206,000. IFP Advisors Inc increased its position in Yahoo! by 7.4% in the first quarter. IFP Advisors Inc now owns 8,518 shares of the digital content provider’s stock valued at $314,000 after buying an additional 587 shares during the last quarter. Reynolds Capital Management LLC acquired a new position in Yahoo! during the first quarter valued at $368,000. E&G Advisors LP increased its position in Yahoo! by 9.5% in the fourth quarter. E&G Advisors LP now owns 10,350 shares of the digital content provider’s stock valued at $344,000 after buying an additional 900 shares during the last quarter. Finally, Howard Hughes Medical Institute increased its position in Yahoo! by 6.1% in the first quarter. Howard Hughes Medical Institute now owns 13,294 shares of the digital content provider’s stock valued at $489,000 after buying an additional 766 shares during the last quarter.

Several other research firms have also weighed in on YHOO. Evercore ISI reiterated a “hold” rating and issued a $37.00 target price on shares of Yahoo! in a report on Thursday, April 21st. Needham & Company LLC restated a “buy” rating and set a $40.00 price objective on shares of Yahoo! in a report on Thursday, April 21st. Jefferies Group restated a “buy” rating and set a $43.00 price objective (up from $40.00) on shares of Yahoo! in a report on Thursday, April 21st. Pacific Crest restated an “equal weight” rating on shares of Yahoo! in a report on Thursday, April 21st. Finally, B. Riley restated a “neutral” rating and set a $38.00 price objective on shares of Yahoo! in a report on Friday, April 22nd. One analyst has rated the stock with a sell rating, twenty have assigned a hold rating and twenty-three have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $41.92.

Yahoo! (NASDAQ:YHOO) traded up 3.29% during midday trading on Thursday, hitting $36.76. The company had a trading volume of 16,285,747 shares. The firm’s market cap is $34.89 billion. The stock has a 50 day moving average of $36.86 and a 200 day moving average of $33.53. Yahoo! has a 52-week low of $26.15 and a 52-week high of $43.78.

Yahoo! Inc is a technology company. The Company is engaged in providing Internet search, communication and digital content. The Company manages its business geographically: the Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific. The Company’s products include Search, Communications, Digital content, Flickr, and Tumblr.

To view Vetr’s full report, visit Vetr’s official website.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.